Found: 4
Select item for more details and to access through your institution.
Evolution of Influenza A(H3N2) Viruses in 2 Consecutive Seasons of Genomic Surveillance, 2021–2023.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 12, p. 1, doi. 10.1093/ofid/ofad577
- By:
- Publication type:
- Article
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 1, p. 652, doi. 10.1002/ehf2.13154
- By:
- Publication type:
- Article
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy.
- Published in:
- Neurology & Therapy, 2021, v. 10, n. 1, p. 375, doi. 10.1007/s40120-021-00235-6
- By:
- Publication type:
- Article
Antisense Inhibition of Glucagon Receptor by IONIS-GCGR<sub>Rx</sub> Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article